Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Japan Specialty Medical Chairs Market

ID: MRFR/MED/52208-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026

Japan Specialty Medical Chairs Market Research Report By Application (Dental, Podiatry, Ophthalmology, Physiotherapy, Surgery), By Type (Electric Chairs, Manual Chairs, Hydraulic Chairs, Height Adjustable Chairs), By Material (Metal, Plastic, Fabric, Carbon Fiber) and By End Use (Hospitals, Clinics, Homecare) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Japan Specialty Medical Chairs Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Chemicals and Materials, BY Application (USD Million)
  49.     4.1.1 Orthopedic
  50.     4.1.2 Dental
  51.     4.1.3 Dialysis
  52.     4.1.4 Psychiatric
  53.     4.1.5 Physical Therapy
  54.   4.2 Chemicals and Materials, BY Chair Type (USD Million)
  55.     4.2.1 Examination Chairs
  56.     4.2.2 Procedure Chairs
  57.     4.2.3 Reclining Chairs
  58.     4.2.4 Wheelchair Accessible Chairs
  59.   4.3 Chemicals and Materials, BY Material (USD Million)
  60.     4.3.1 Plastic
  61.     4.3.2 Metal
  62.     4.3.3 Wood
  63.     4.3.4 Vinyl
  64.     4.3.5 Foam
  65.   4.4 Chemicals and Materials, BY End User (USD Million)
  66.     4.4.1 Hospitals
  67.     4.4.2 Clinics
  68.     4.4.3 Home Care
  69.     4.4.4 Rehabilitation Centers
  70. 5 SECTION V: COMPETITIVE ANALYSIS
  71.   5.1 Competitive Landscape
  72.     5.1.1 Overview
  73.     5.1.2 Competitive Analysis
  74.     5.1.3 Market share Analysis
  75.     5.1.4 Major Growth Strategy in the Chemicals and Materials
  76.     5.1.5 Competitive Benchmarking
  77.     5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  78.     5.1.7 Key developments and growth strategies
  79.       5.1.7.1 New Product Launch/Service Deployment
  80.       5.1.7.2 Merger & Acquisitions
  81.       5.1.7.3 Joint Ventures
  82.     5.1.8 Major Players Financial Matrix
  83.       5.1.8.1 Sales and Operating Income
  84.       5.1.8.2 Major Players R&D Expenditure. 2023
  85.   5.2 Company Profiles
  86.     5.2.1 Invacare Corporation (US)
  87.       5.2.1.1 Financial Overview
  88.       5.2.1.2 Products Offered
  89.       5.2.1.3 Key Developments
  90.       5.2.1.4 SWOT Analysis
  91.       5.2.1.5 Key Strategies
  92.     5.2.2 Hill-Rom Holdings Inc (US)
  93.       5.2.2.1 Financial Overview
  94.       5.2.2.2 Products Offered
  95.       5.2.2.3 Key Developments
  96.       5.2.2.4 SWOT Analysis
  97.       5.2.2.5 Key Strategies
  98.     5.2.3 Stryker Corporation (US)
  99.       5.2.3.1 Financial Overview
  100.       5.2.3.2 Products Offered
  101.       5.2.3.3 Key Developments
  102.       5.2.3.4 SWOT Analysis
  103.       5.2.3.5 Key Strategies
  104.     5.2.4 Medline Industries Inc (US)
  105.       5.2.4.1 Financial Overview
  106.       5.2.4.2 Products Offered
  107.       5.2.4.3 Key Developments
  108.       5.2.4.4 SWOT Analysis
  109.       5.2.4.5 Key Strategies
  110.     5.2.5 Graham-Field Health Products Inc (US)
  111.       5.2.5.1 Financial Overview
  112.       5.2.5.2 Products Offered
  113.       5.2.5.3 Key Developments
  114.       5.2.5.4 SWOT Analysis
  115.       5.2.5.5 Key Strategies
  116.     5.2.6 Drive DeVilbiss Healthcare (US)
  117.       5.2.6.1 Financial Overview
  118.       5.2.6.2 Products Offered
  119.       5.2.6.3 Key Developments
  120.       5.2.6.4 SWOT Analysis
  121.       5.2.6.5 Key Strategies
  122.     5.2.7 Karma Medical Products Co Ltd (TW)
  123.       5.2.7.1 Financial Overview
  124.       5.2.7.2 Products Offered
  125.       5.2.7.3 Key Developments
  126.       5.2.7.4 SWOT Analysis
  127.       5.2.7.5 Key Strategies
  128.     5.2.8 Joerns Healthcare LLC (US)
  129.       5.2.8.1 Financial Overview
  130.       5.2.8.2 Products Offered
  131.       5.2.8.3 Key Developments
  132.       5.2.8.4 SWOT Analysis
  133.       5.2.8.5 Key Strategies
  134.     5.2.9 Arjo AB (SE)
  135.       5.2.9.1 Financial Overview
  136.       5.2.9.2 Products Offered
  137.       5.2.9.3 Key Developments
  138.       5.2.9.4 SWOT Analysis
  139.       5.2.9.5 Key Strategies
  140.   5.3 Appendix
  141.     5.3.1 References
  142.     5.3.2 Related Reports
  143. 6 LIST OF FIGURES
  144.   6.1 MARKET SYNOPSIS
  145.   6.2 JAPAN MARKET ANALYSIS BY APPLICATION
  146.   6.3 JAPAN MARKET ANALYSIS BY CHAIR TYPE
  147.   6.4 JAPAN MARKET ANALYSIS BY MATERIAL
  148.   6.5 JAPAN MARKET ANALYSIS BY END USER
  149.   6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
  150.   6.7 RESEARCH PROCESS OF MRFR
  151.   6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
  152.   6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  153.   6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  154.   6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
  155.   6.12 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
  156.   6.13 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
  157.   6.14 CHEMICALS AND MATERIALS, BY CHAIR TYPE, 2024 (% SHARE)
  158.   6.15 CHEMICALS AND MATERIALS, BY CHAIR TYPE, 2024 TO 2035 (USD Million)
  159.   6.16 CHEMICALS AND MATERIALS, BY MATERIAL, 2024 (% SHARE)
  160.   6.17 CHEMICALS AND MATERIALS, BY MATERIAL, 2024 TO 2035 (USD Million)
  161.   6.18 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
  162.   6.19 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
  163.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  164. 7 LIST OF TABLES
  165.   7.1 LIST OF ASSUMPTIONS
  166.     7.1.1
  167.   7.2 Japan MARKET SIZE ESTIMATES; FORECAST
  168.     7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  169.     7.2.2 BY CHAIR TYPE, 2025-2035 (USD Million)
  170.     7.2.3 BY MATERIAL, 2025-2035 (USD Million)
  171.     7.2.4 BY END USER, 2025-2035 (USD Million)
  172.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  173.     7.3.1
  174.   7.4 ACQUISITION/PARTNERSHIP
  175.     7.4.1

Japan Chemicals and Materials Market Segmentation

Chemicals and Materials By Application (USD Million, 2025-2035)

  • Orthopedic
  • Dental
  • Dialysis
  • Psychiatric
  • Physical Therapy

Chemicals and Materials By Chair Type (USD Million, 2025-2035)

  • Examination Chairs
  • Procedure Chairs
  • Reclining Chairs
  • Wheelchair Accessible Chairs

Chemicals and Materials By Material (USD Million, 2025-2035)

  • Plastic
  • Metal
  • Wood
  • Vinyl
  • Foam

Chemicals and Materials By End User (USD Million, 2025-2035)

  • Hospitals
  • Clinics
  • Home Care
  • Rehabilitation Centers

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions